What are the VA rating percentages for Leukemia?

Leukemia (DC 7703) is rated at 100%, 0% under 38 CFR § 4.117, DC 7703 (Leukemia, except CML). When there is active disease or during a treatment phase

What rates 100% for Leukemia under 38 CFR § 4.117, DC 7703 (Leukemia, except CML)?

Under 38 CFR § 4.117, DC 7703 (Leukemia, except CML) (DC 7703), a 100% rating for Leukemia requires: When there is active disease or during a treatment phase

What rates 0% for Leukemia under 38 CFR § 4.117, DC 7703 (Leukemia, except CML)?

Under 38 CFR § 4.117, DC 7703 (Leukemia, except CML) (DC 7703), a 0% rating for Leukemia requires: Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0

What happens during a C&P exam for Leukemia?

Blood-disorder ratings turn on objective measures - platelet counts, transfusion frequency, and the intensity of treatment (38 CFR 4.117). Bring your recent CBC and lab results. For immune thrombocytopenia (DC 7705), the rating is driven by your platelet count and whether you require chemotherapy or immunosuppressive therapy - document both.

← All Condition Guides

CLAIMRECON INTEL

Leukemia

Q: What evidence do I need for a Leukemia VA claim?

Key evidence for a Leukemia claim includes: Recent CBC and lab reports showing platelet count, hemoglobin, and neutrophil/ANC values; Transfusion records showing the number of platelet or red-cell transfusions per 12 months; A dated log of painful (vaso-occlusive) crises (sickle cell anemia); Hematology/oncology records documenting active disease or treatment-phase dates; Documentation of treatment intensity (continuous medication, immunosuppressive therapy, growth factors, or chemotherapy). All evidence should document both the condition and its impact on daily functioning.

DC 770338 C.F.R. § 4.117, DC 7703 (Leukemia, except CML)

Diagnostic Code

DC 7703

38 C.F.R. § 4.117, DC 7703 (Leukemia, except CML)

Rating Range

0–100%

2 severity tiers

Source

Verified

38 C.F.R. § 4.117

Leukemia is rated by the U.S. Department of Veterans Affairs under DC 7703 of 38 CFR § 4.117, DC 7703 (Leukemia, except CML) across 2 severity tiers (100% / 0%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Cancer of the blood-forming tissues including bone marrow. Types include ALL, AML, CLL, and CML. Rated 100% during active disease. Presumptive for Agent Orange, radiation, and certain toxic exposures.

Rating Criteria

100%

When there is active disease or during a treatment phase

Chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis (MBL), asymptomatic, Rai Stage 0

Key Evidence

—Recent CBC and lab reports showing platelet count, hemoglobin, and neutrophil/ANC values

—Transfusion records showing the number of platelet or red-cell transfusions per 12 months

—A dated log of painful (vaso-occlusive) crises (sickle cell anemia)

—Hematology/oncology records documenting active disease or treatment-phase dates

—Documentation of treatment intensity (continuous medication, immunosuppressive therapy, growth factors, or chemotherapy)

—Bone marrow biopsy or other diagnostic reports confirming the condition

C&P Exam Tips

1Blood-disorder ratings turn on objective measures - platelet counts, transfusion frequency, and the intensity of treatment (38 CFR 4.117). Bring your recent CBC and lab results.

2For immune thrombocytopenia (DC 7705), the rating is driven by your platelet count and whether you require chemotherapy or immunosuppressive therapy - document both.

3For anemias requiring transfusion (for example, aplastic anemia, myelodysplastic syndromes), count how many transfusions of platelets or red cells you need per 12 months - that frequency sets the level.

4For sickle cell anemia (DC 7714), the rating counts painful (vaso-occlusive) crises per 12 months and the level of work you can still do - keep a dated log of every crisis.

5Active disease or an active treatment phase (chemotherapy) often supports a 100% evaluation for blood cancers - make sure your treatment dates are on the record.

6Report how fatigue, infections, or bleeding affect work and daily activity, and list all medications including any continuous or immunosuppressive therapy.

More in Hematologic & Lymphatic

Lymphedema Lymphoma (Non-Hodgkin's)Monoclonal Gammopathy of Undetermined Significance (MGUS)Multiple Myeloma Myelodysplastic Syndrome Myelodysplastic Syndrome Non-Hodgkin Lymphoma Non-Hodgkin's Lymphoma All Hematologic & Lymphatic conditions →All conditions →

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.117 (Hemic and lymphatic systems). Source verified 2026-06-05 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.117 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIMRECON 2026

LOADING